Time to Maximum Plasma Concentration of Motesanib (Tmax) for Cycle 1 Cycle 1, Day 3 at predose, 15 and 30 minutes, and at 1, 2, 4, 6, 10 (QD cohorts only), and 24 hours post-dose. [clinicaltrials_resource:d0d0078c71846551f5028ff6c32aa43e]
The time after dosing that the maximal plasma concentration of motesanib was observed in Cycle 1. For the 75 mg BID cohorts, Tmax is reported for the first daily dose.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Time to Maximum Plasma Concentration of Motesanib (Tmax) for Cycle 1 Cycle 1, Day 3 at predose, 15 and 30 minutes, and at 1, 2, 4, 6, 10 (QD cohorts only), and 24 hours post-dose. [clinicaltrials_resource:d0d0078c71846551f5028ff6c32aa43e]
The time after dosing that the maximal plasma concentration of motesanib was observed in Cycle 1. For the 75 mg BID cohorts, Tmax is reported for the first daily dose.
Bio2RDF identifier
d0d0078c71846551f5028ff6c32aa43e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d0d0078c71846551f5028ff6c32aa43e
measure [clinicaltrials_vocabulary:measure]
Time to Maximum Plasma Concentration of Motesanib (Tmax) for Cycle 1
time frame [clinicaltrials_vocabulary:time-frame]
Cycle 1, Day 3 at predose, 15 ...... only), and 24 hours post-dose.
description
The time after dosing that the ...... rted for the first daily dose.
identifier
clinicaltrials_resource:d0d0078c71846551f5028ff6c32aa43e
title
Time to Maximum Plasma Concent ...... only), and 24 hours post-dose.
@en
type
label
Time to Maximum Plasma Concent ...... 0078c71846551f5028ff6c32aa43e]
@en